Welcome to our dedicated page for ASP Isotopes news (Ticker: ASPI), a resource for investors and traders seeking the latest updates and insights on ASP Isotopes stock.
ASP Isotopes Inc. develops isotope enrichment technologies and related critical-materials businesses for nuclear medicine, next-generation semiconductors, nuclear energy and helium markets. Company news commonly covers its Aerodynamic Separation Process and Quantum Enrichment platforms, enrichment facilities in Pretoria, South Africa, and target isotopes such as Silicon-28, Carbon-14 and Ytterbium-176.
Recurring updates also address PET Labs radiopharmaceutical operations, Quantum Leap Energy nuclear fuel-cycle initiatives, lithium laser enrichment research, Renergen and the Virginia Gas Project, material agreements, governance matters, capital-structure disclosures, and operating and financial results.
ASP Isotopes (NASDAQ: ASPI) announced that subsidiary Quantum Leap Energy signed a non-binding MOU with a European advanced nuclear reactor developer to assess long-term HALEU fuel supply. The framework covers uranium feedstock supply, conversion, enrichment above 10% U-235, potential deconversion, and deliveries potentially starting in 2028, with the MOU running through 2030.
Quantum Leap Energy (ASPI) appointed Dr. Peter S. Fiske to its Strategic Advisory Board on May 6, 2026. Dr. Fiske brings experience in technology commercialization, advanced materials, and government partnerships, including leadership of the DOE-backed National Alliance for Water Innovation.
The appointment follows QLE's recent SAB formation, CTO Nate Salpeter hire, and a strategic collaboration with the University of Bristol on a lithium laser research facility.
Skyline Builders Group Holding Ltd and Cove Kaz Capital Group LLC (ASPI) announced a transaction to combine into Kaz Resources Inc. (expected Nasdaq: KAZR) to develop Kazakhstan critical-minerals projects.
Key facts: acquisition closed April 29, 2026; largest undeveloped tungsten resource of 1.4 million tonnes WO3; expected production 12,000 mtpa; EXIM and DFC issued LOIs totaling $1.6 billion; estimated development cost $1.1 billion.
ASP Isotopes (NASDAQ: ASPI) provided a business update on April 13, 2026 outlining near-term commercial milestones, operational progress, and financials. The company expects first commercial shipments across Silicon-28, Carbon-14, and Yb-176 in 2026, and Helium Phase 1 nameplate capacity in Q3 2026. Cash and equivalents were $333 million as of December 31, 2025, product revenue was $5.7 million in 2025, and a long-term EBITDA target of greater than $300 million in 2031 was reiterated.
ASP Isotopes (NASDAQ: ASPI) will host a business update conference call and webcast on Monday, April 13, 2026 at 8:00 AM ET, led by Paul Mann, Executive Chairman and CEO.
Dial-in numbers and Conference ID 5073116 are provided for live participation; a replay will be available at www.aspisotopes.com roughly three hours after the call concludes.
ASP Isotopes (NASDAQ: ASPI) said a UK subsidiary of Quantum Leap Energy has begun a strategic collaboration with the University of Bristol to design a lithium laser enrichment research facility. The University will lead a site-agnostic feasibility and design study in an estimated four-month initial phase, including safety reviews and RIBA Stage 4 technical design.
Subject to a positive feasibility assessment, parties intend to proceed to construction at a suitable Bristol site; work was developed in consultation with UK regulators including the Department for Energy Security and Net Zero and the Office for Nuclear Regulation.
ASP Isotopes (NASDAQ: ASPI) completed drilling for Phase 1 of the Renergen Helium Project about four months ahead of schedule on March 23, 2026. New wells delivered gas flows up to 16x prior wells and the project has reached Phase 1 nameplate flow, reducing execution risk.
ASP expects Phase 1 to produce 2,500 GJ/day LNG and 58 MCF/day helium, and Phase 2 to target 34,000 GJ/day LNG and 895 MCF/day helium after a 44-month build.
ASP Isotopes (NASDAQ: ASPI) announced that CEO Paul Mann will appear in a fireside chat at Canaccord Genuity’s 2nd Annual CG Virtual Sustainability Summit on Thursday, March 12, 2026 at 3:20 p.m. ET.
A live audio webcast will be available in the Company’s Investors section and a replay posted within 48 hours after the event.
ASP Isotopes (NASDAQ: ASPI) subsidiary Quantum Leap Energy entered a non-binding MOU with a large U.S. energy company to evaluate support for U.S.-based advanced nuclear fuel facilities. The facilities are planned to produce HALEU, LEU+, and provide conversion/deconversion services to strengthen the domestic supply chain.
QLE said the MOU outlines potential financial support terms tied to definitive supply agreements and anticipates technical diligence and pathways toward long-term commercial collaboration.
ASP Isotopes (NASDAQ: ASPI) announced that Quantum Leap Energy appointed Dr. Nate Salpeter as Chief Technology Officer on March 5, 2026. Dr. Salpeter brings over 15 years of experience building computational and experimental programs at TerraPower, Kairos Power, and other organizations.
He will focus on optimizing in-licensed and proprietary technologies, standing up computational and experimental frameworks, implementing rapid learning cycles, and leading disciplined de-risking to advance QLE's commercialization objectives.